Welcome, Guest
Username: Password: Remember me
Cytori´s Platform applications
  • Page:
  • 1

TOPIC: Raynaud's Phenomenon Video

Raynaud's Phenomenon Video 16 Jul 2017 09:34 #9588

  • DOV
  • DOV's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 347
  • Thank you received: 194
sclerodermanews.com/2016/05/09/raynauds-phenomenon-in-real-time/

Scleradec I showed a 69% improvement in Raynaud's Condition Score at 6 months (P<.001). At 36 months the improvement was 90% from original baseline (P<.0001)

The TAM (total available market) for Raynaud's is 20x larger than Scleroderma according to Hedrick's data source. What I found interesting in this link was the comment that Raynaud's phenomenon is a precursor to Scleroderma. As with all of these autoimmune diseases, the sooner the condition is diagnosed and treated the better.
The following user(s) said Thank You: Joncon63

Please Log in or Create an account to join the conversation.

Raynaud's Phenomenon Video 16 Jul 2017 10:17 #9591

  • Old Young Fox
  • Old Young Fox's Avatar
  • Offline
  • Expert Boarder
  • Expert Boarder
  • Posts: 101
  • Thank you received: 12
The National Institute of Arthritis and Musculoskeletal and Skin Diseases estimates that the number of people in the United States with systemic sclerosis ranges from 40,000 to 165,000. A survey that included all scleroderma-related disorders, including Raynaud's phenomenon, suggested a number between 250,000 and 992,500.

This numbers show also the much more bigger market for Raynaud's phenomenon

Please Log in or Create an account to join the conversation.

holdi

Raynaud's Phenomenon Video 21 Jul 2017 15:02 #9612

  • Old Young Fox
  • Old Young Fox's Avatar
  • Offline
  • Expert Boarder
  • Expert Boarder
  • Posts: 101
  • Thank you received: 12
source: Cytori 10 Jan 2017 press releaseHabeo

In addition to its substantial contribution to the disease burden of scleroderma, RP is a source of significant morbidity in several more common autoimmune and inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus (lupus), and Sjogren’s syndrome. The worldwide prevalence of moderate-to-severe RP in these three diseases alone exceeds one million patients, providing an estimated peak annual revenue potential of $1.6 billion.

habeo

Please Log in or Create an account to join the conversation.

holdi
  • Page:
  • 1
Time to create page: 0.107 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites